Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 71 |
|
|||||
| News | - | ||||||
| Day High | 4.75 | Low High |
|||||
| Day Low | 4.75 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| PolyPid Ltd | PYPD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0221 | -0.46% | 4.75 | 09:51:52 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.75 | 4.75 | 4.75 | 4.7721 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 4 | 71 | - | 3.5655 - 13.482 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:02:09 | 9 | US$ 4.79 | USD |
PolyPid Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.89M | 1.65M | - | 0 | -23.87M | -14.43 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
PolyPid News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PYPD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.40 | 4.8999 | 4.08 | 4.72 | 1,702 | 0.35 | 7.95% |
| 1 Month | 4.89 | 4.95 | 4.08 | 4.55 | 3,161 | -0.14 | -2.86% |
| 3 Months | 6.74 | 7.00 | 4.08 | 5.17 | 3,223 | -1.99 | -29.53% |
| 6 Months | 3.81 | 9.20 | 3.61 | 5.56 | 4,933 | 0.94 | 24.67% |
| 1 Year | 12.60 | 13.482 | 3.5655 | 9.52 | 44,026 | -7.85 | -62.30% |
| 3 Years | 276.30 | 289.20 | 3.5655 | 52.61 | 149,192 | -271.55 | -98.28% |
| 5 Years | 480.00 | 583.50 | 3.5655 | 86.47 | 129,727 | -475.25 | -99.01% |
PolyPid Description
| PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies. |
